Differentiating hypersensitivity versus infusion-related reactions in pediatric patients receiving intravenous asparaginase therapy for acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Differentiating hypersensitivity versus infusion-related reactions in pediatric patients receiving intravenous asparaginase therapy for acute lymphoblastic leukemia

Published:2016-08-22 Issue:3 Volume:58 Page:540-551
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Burke Michael J.¹,Rheingold Susan R.²

Affiliation:

1. Division of Pediatric Oncology, Medical College of Wisconsin, Milwaukee, WI, USA;

2. Division of Oncology, The Children’s Hospital of Philadelphia, Philadelphia, PA, USA

Funder

Jazz Pharmaceuticals

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://tandfonline.com/doi/pdf/10.1080/10428194.2016.1213826

Reference98 articles.

1. Children's Oncology Group's 2013 blueprint for research: acute lymphoblastic leukemia

2. Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95

3. L-asparaginase treatment in acute lymphoblastic leukemia

4. Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985–2000)

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The structural insights of L-asparaginase from Pseudomonas aeruginosa CSPS4 at elevated temperatures highlight its thermophilic nature;3 Biotech;2024-09-11

2. Asparaginase: Optimizing Efficacy and Minimizing Toxicity in Pediatric and AYA ALL/LBL;Clinical Lymphoma Myeloma and Leukemia;2024-09

3. Coronavirus Disease 2019 mRNA Vaccination Appears Safe in Pediatric Patients With Hypersensitivity to Polyethylene Glycolated Escherichia coli L-asparaginase;Journal of Pediatric Hematology/Oncology;2024-01-05

4. Lack of benefit from premedication for pegylated asparaginase during pediatric acute lymphoblastic leukemia/lymphoma therapy: A side‐by‐side comparison;Pediatric Blood & Cancer;2023-10-19

5. Review of molecular biological studies on acute lymphoblastic leukemia treated by modified shengmaiyin;Medicine;2023-06-09